Citarabina liposomal para el tratamiento de la diseminación leptomeníngea en tumores del sistema nervioso central en niños y adolescentes

  1. Lucas Moreno
  2. Miguel Angel García Ariza
  3. Ofelia Cruz
  4. Carlota Calvo
  5. Jose Luis Fuster
  6. Jose Antonio Salinas
  7. Cristina Moscardo
  8. Raquel Portugal
  9. Jose Manuel Merino
  10. Luis Madero
Revue:
Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP )

ISSN: 1695-4033 1696-4608

Année de publication: 2016

Volumen: 85

Número: 5

Pages: 274-274

Type: Article

DOI: 10.1016/J.ANPEDI.2016.02.007 DIALNET GOOGLE SCHOLAR lock_openAccès ouvert editor

D'autres publications dans: Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP )

Résumé

Leptomeningeal dissemination in paediatric central nervous system (CNS) tumours is associated with a poor outcome, and new therapeutic strategies are desperately needed. One of the main difficulties in the treatment of CNS tumours is blood brain barrier penetration. Intrathecal therapy has shown to be effective in several paediatric tumours. The aim of this article is to review the data available on the use of liposomal cytarabine for paediatric patients with leptomeningeal dissemination of CNS tumours, including the pharmacology, administration route, safety and efficacy data.